文献速递生殖医学妇科

年轻原发性卵巢功能不全和早期绝经女性的激素替代治疗

Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
PubMed 文献 · Fertil Steril · 2016-01-01

本文综述原发性卵巢功能不全(POI)及其相关健康风险,并讨论安全有效的激素替代治疗(HRT)方案。作者推荐使用最接近模拟正常卵巢激素产生的HRT制剂,并持续至自然绝经的正常年龄约50岁。

要点

  • POI与多种健康风险相关,包括血管舒缩症状、骨密度降低和骨折风险增加、心血管疾病早期进展、心理影响及认知潜在早期下降。
  • 适当的HRT替代绝经前卵巢性激素水平对提高POI女性生活质量和改善相关健康风险至关重要。
  • 作者推荐使用最接近模拟正常卵巢激素产生的HRT制剂,并持续至自然绝经的正常年龄约50岁。

核心结论

  • 为降低POI相关发病率,作者推荐使用最接近模拟正常卵巢激素产生的HRT制剂,并持续HRT至自然绝经的正常年龄约50岁。

研究设计与样本

  • 本文为综述,讨论POI及其相关并发症以及安全有效的HRT方案。

主要发现

  • POI是女性卵巢激素缺乏和不孕的罕见但重要原因,并与多种健康风险相关,包括烦人的绝经症状、骨密度降低和骨折风险增加、心血管疾病早期进展、可能包括抑郁和焦虑的心理影响及感知社会心理支持下降、认知潜在早期下降和干眼综合征。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary ovarian insufficiency (POI) is a rare but important cause of ovarian hormone deficiency and infertility in women. In addition to causing infertility, POI is associated with multiple health risks, including bothersome menopausal symptoms, decreased bone density and increased risk of fractures, early progression of cardiovascular disease, psychologic impact that may include depression, anxiety, and decreased perceived psychosocial support, potential early decline in cognition, and dry eye syndrome. Appropriate hormone replacement therapy (HRT) to replace premenopausal levels of ovarian sex steroids is paramount to increasing quality of life for women with POI and ameliorating associated health risks. In this review, we discuss POI and complications associated with this disorder, as well as safe and effective HRT options. To decrease morbidity associated with POI, we recommend using HRT formulations that most closely mimic normal ovarian hormone production and continuing HRT until the normal age of natural menopause, ∼50 years. We address special populations of women with POI, including women with Turner syndrome, women with increased risk of breast or ovarian cancer, women approaching the age of natural menopause, and breastfeeding women.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Sullivan SD, Sarrel PM, Nelson LM, et al. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016. PMID: 27912889. doi:10.1016/j.fertnstert.2016.09.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。